Caditam

Product Overview

Caditam is a medication containing the active ingredient Tamoxifen (20mg) and is available in tablet form. It belongs to a class of drugs known as selective estrogen receptor modulators (SERMs). Caditam is commonly prescribed for the treatment of breast cancer, particularly hormone receptor-positive breast cancer, as well as for reducing the risk of breast cancer recurrence in certain patients. It works by blocking the effects of estrogen in breast tissue, thereby slowing or stopping the growth of cancer cells.

Uses

Caditam is primarily used in the treatment of breast cancer, both as adjuvant therapy after surgery or radiation and as a first-line treatment for metastatic breast cancer. Additionally, it may be prescribed for reducing the risk of developing breast cancer in high-risk individuals, such as those with a family history of the disease or certain genetic mutations.

How to Use

Caditam tablets should be taken orally, with or without food, as directed by a healthcare professional. It is typically taken once or twice daily for a specified duration of treatment. It is important to swallow the tablets whole with a full glass of water, without crushing or chewing them. Patients should follow the dosage instructions provided by their doctor closely and not exceed the recommended dose.

How it Works

Tamoxifen, the active ingredient in Caditam, works by binding to estrogen receptors on breast cancer cells, blocking the effects of estrogen. This inhibits the growth of hormone-sensitive breast cancer cells and may induce cell death. In addition to its anti-estrogenic effects in breast tissue, Tamoxifen may also exert estrogen-like effects in other tissues, providing benefits such as preserving bone density in postmenopausal women.

Dosage and Administration

The recommended dosage of Caditam varies depending on the specific indication and individual patient factors. It is typically started at a lower dose and gradually increased as tolerated. Treatment duration may range from several months to several years, depending on the stage and aggressiveness of the breast cancer. Patients should adhere to the prescribed dosage and schedule provided by their healthcare provider.

Benefits

• Effective treatment for hormone receptor-positive breast cancer
• Reduces the risk of breast cancer recurrence
• May lower the risk of developing breast cancer in high-risk individuals
• Well-tolerated with manageable side effects

Common Side Effects

Common side effects of Caditam may include hot flashes, vaginal dryness, irregular menstrual periods, nausea, and fatigue. Some patients may also experience mood changes, such as depression or anxiety, as well as an increased risk of blood clots. It is important to report any persistent or severe side effects to a healthcare provider promptly.

Warnings

Caditam may increase the risk of developing uterine cancer, blood clots, and other serious side effects. Patients with a history of blood clots, stroke, or endometrial cancer should use Caditam with caution and discuss the risks and benefits with their doctor. Regular monitoring and follow-up appointments are essential for patients taking Caditam to assess treatment response and monitor for potential complications.

Storage Information

Store Caditam tablets at room temperature, away from moisture and heat. Keep the medication out of reach of children and pets. Do not use Caditam past its expiration date.

Disclaimer:

Our sole intention is to ensure that its consumers get information that is expert-reviewed, accurate, and trustworthy. However, the information contained herein should NOT be used as a substitute for the advice of a qualified physician. The information provided here is for informational purposes only. This may not cover all possible side effects, drug interactions, or warnings or alerts. Please consult your doctor and discuss all your queries related to any disease or medicine. We intend to support, not replace, the doctor-patient relationship.